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Functional requirement of aquaporin-5 in plasma membranes of sweat glands
Lene N. Nejsum, Tae-Hwan Kwon, [...], and Søren Nielsen

ABSTRACT
The distribution and function of aquaporins (AQPs) have not previously been defined in sweat glands. In this study, AQP1, AQP3, and
AQP5 mRNA were demonstrated in rat paw by reverse transcription (RT)–PCR, but AQP2 and AQP4 were not. AQP1, AQP3, and
AQP5 protein were confirmed in these tissues by immunoblotting. AQP1 was identified in capillary endothelial cells by
immunohistochemical labeling, but not in sweat glands or epidermis. Abundant AQP3 expression was seen in basal levels of epidermis,
but not in sweat glands. AQP2 and AQP4 were not observed in either skin or sweat glands. Immunohistochemical labeling revealed
abundant AQP5 in secretory parts of rat and mouse sweat glands, where immunoelectron microscopy demonstrated abundant AQP5
labeling in the apical plasma membrane. AQP5 immunolabeling of human sweat glands yielded a similar pattern. To establish the role of
AQP5 in sweat secretion, we tested the response of adult mice to s.c. injection of pilocarpine, as visualized by reaction of secreted
amylase with iodine/starch. The number of active sweat glands was dramatically reduced in AQP5null (−/−) mice compared with
heterozygous (+/−) and wildtype (+/+) mice. We conclude that the presence of AQP5 in plasma membranes of sweat glands is essential
for secretion, providing potential insight into mechanisms underlying mammalian thermoregulation, tactile sensitivity, and the
pathophysiology of hyperhidrosis.
Aquaporins (AQPs) are a family of membrane water channel proteins. Eleven mammalian AQPs are known, and several have been
implicated in physiological processes and human diseases as predicted by the sites of expression. AQP1 resides in the plasma membranes
of renal proximal tubules and descending thin limbs (1), and humans with AQP1 mutations exhibit defective urinary concentration (2).
AQP1 is also abundant in capillary endothelium (3), facilitating movement of water between lumen and interstitium (4). AQP0 is
abundant in lens fiber cells, and families with AQP0 mutations suffer congenital cataracts (5). AQP2 is expressed in renal collecting duct
principal cells where it is shuttled from intracellular sites to the plasma membrane in response to vasopressin activation of adenylyl
cyclase (6), and humans with AQP2 mutations have severe nephrogenic diabetes insipidus (7). AQP5 is usually expressed in apical plasma
membranes of secretory glands (8), and transgenic mice lacking AQP5 are deficient in pilocarpineinduced salivation (9). Although
AQP5 expression is not known to be impaired, humans suffering from Sjögren's syndrome experience decreased tear and saliva formation,
and AQP5 is retained in intracellular sites (10, 11).
Sweating is essential for thermoregulation in many species, and sweat glands in the footpads of rodents are believed to enhance tactile
sensitivity (12, 13). It is yet unknown whether specific aquaporins are present in sweat glands. Patients with Sjögren's syndrome also have
difficulty in perspiring (hypohidrosis/anhidrosis) and exhibit markedly decreased sweating in response to methacholine stimulation (14,
15). Thus, AQP5 may play a significant role in sweat secretion, and the pathogenesis of hypohidrosis, observed in patients with Sjögren's
syndrome, could be related to disregulation of AQP5 expressed in sweat glands.
This study was undertaken to define the localization of AQPs 1 through 5 in rat and mouse skin and sweat glands and to investigate the
potential roles of AQPs in sweat secretion. Our studies demonstrate that AQP5 resides in plasma membranes of sweat secretory cells and
is essential for sweat secretion.

METHODS
Experimental Animals. Male Wistar rats (180–260 g) and male Naval Medical Research Institute mice (20–30 g, M & B, Ry, Denmark)
were maintained on standard rodent diet (Altromin, Lage, Germany) with free access to water. AQP5null (−/−) mice, heterozygous (+/
−), and wildtype (+/+) littermates have been described (16).
RNA Extraction and RT-PCR. Total RNA was extracted by a conventional method (17). Reverse transcription of total RNA used Superscript
(Life Technologies, Tåstrup, Denmark). PCR was performed for 30 cycles with sequencespecific sense and antisense oligonucleotide
primers: AQP1: GGCCATGACCCTCTTCGTCT, GAGCAGAAGCCCCAGTGTGA; AQP2: AGCAGCATGTGGGAACTCAGATCC,
AGCTCAGGCCTTGCTGCCGCGAGG; AQP3: CCATCTACACACTGGCACAGAC, ACATTCTCTGCCTCAGTGGAAG (18);
AQP4: CATCGCCAAGTCTGTCTTCTACA, ACCTCTCCAGACGAGTCCTTCC (18); AQP5:
CAAGGCGGTGTTCGCAGAGTTCC, CCTCTCGATGATCTTCCCAGTCC (18); βactin: GAGTACAACCTCCTTGCAGCTC,

TTGTAGAAAGTGTGGTGCCAAA.
Negative PCR controls included omission of reverse transcriptase or omission of cDNA. Products were confirmed by highstringency
Southern blotting with sequencespecific cDNA probes (data not shown).
Primary Antibodies. Immune serum or affinitypurified antibodies included: AQP1 (CHIP serum or LL266AP) (1); AQP2 (LL127 serum
or LL127AP) (6, 19); AQP3 (LL178AP) (20); AQP4 (LL182 serum or LL182AP) (21); AQP5 (22, 23). Affinitypurified polyclonal
antibodies were also raised against the Cterminal region (amino acids 248–267) of rat and mouse AQP1 (RA3391/2353AP) and the C
terminal region (amino acid 261–285) of rat AQP3 (RA3040/1592AP).
Membrane Fractionation and Immunoblotting. Tissues were homogenized for 20–30 sec and centrifuged at 4,000 × g for 15 min at 4°C. The
resulting supernatant was centrifuged at 200,000 × g for 1 h to produce a pellet containing plasma membranes and intracellular vesicles.
Samples (2% SDS) were run on SDS12% polyacrylamide Laemmli minigels, transferred to nitrocellulose membranes, incubated
overnight with rat primary antibodies, and visualized with horseradish peroxidaseconjugated secondary antibody (P0448, DAKO,
Glostrup, Denmark) by enhanced chemiluminiscence (Amersham Pharmacia) (6).
Immunohistochemistry. Experimental animals were fixed by cardiac perfusion with 3% paraformaldehyde in 0.1 M cacodylate buffer, and
tissues were extracted for paraffin embedding and sectioning. Paraffin sections (2 μm) were incubated overnight at 4°C with primary
antibodies and visualized with horseradish peroxidaseconjugated secondary antibody (above). Punch biopsies of human tissues were
incubated in 25 units/ml dispase (Roche Molecular Biomedicals, Hvidovre, Denmark) overnight on ice. The epidermis including intact
sweat glands was gently removed from the dermis and fixed in neutral buffered formalin, rinsed, and kept in PBS with sodium azide. For
staining, tissues were blocked in PB buffer (PBS, 0.3% Triton, 1% skimmed milk powder) and incubated overnight with human AQP5
antibody. Labeling was visualized with Alexa Fluor488 (Molecular Probes). Confocal microscopy used a Leica TCR2 (Leica, Deerfield,
IL).
Immunoelectron Microscopy. Ultrathin Lowicryl HM20 sections (40–80 nm) were incubated overnight at 4°C with rat antiAQP5 antibodies
(11, 22, 23) and visualized with goat antirabbit IgG conjugated to 10nm colloidal gold particles at 1:50 (GAR.EM10, BioCell Research
Laboratories, Cardiff, U.K.). Sections stained with uranyl acetate and lead citrate were examined with a Philips CM100 or Philips 208
electron microscope (Philips, Eindhoven, The Netherlands).
In Vivo Sweat Response. Determination of pilocarpineinduced sweating was quantitated by a slightly modified standard method (24), in
which secreted amylase was detected by its reaction with iodine and starch. Adult AQP5null (−/−) mice, heterozygous (+/−), and wild
type (+/+) were anesthetized (0.66 ml ketamine/0.22 ml xylazine in 2.5 ml isotonic NaCl; dose 0.625 ml per 100 g body weight). Right
hind paws were painted with 3.5% iodine in ethanol and coated with 10% starch solution in mineral oil. Pilocarpine (50 μg) was injected
s.c. into the paws, and digital photos taken every 15 sec for up to 5 min. Black spots were counted 2 min after pilocarpine injection.
Results are indicated as fraction of controls (wild type).

RESULTS
Detection of AQP5 mRNA by RT-PCR and Immunoblotting. RTPCR was performed on total RNA from rat paws (Fig. 1) by using specific
primers. Rat kidneys and lungs were positive controls. Consistent with evidence that AQP1 is present in capillary endothelia (3, 25) and
AQP3 in the basal layer of the skin epithelium (26), AQP1 and AQP3 primers produced bands in samples from rat paws and kidneys.
AQP5 primers also produced a band in rat paws, identifying a previously unrecognized site for AQP5 expression. AQP2 and AQP4
primers failed to amplify mRNA from rat paws, but bands were produced from positive controls. Thus, AQP1, AQP3, and AQP5 mRNA
were all detected in rat paws.

Figure 1
RTPCR analysis of rat paws. Products of the predicted sizes were generated by RTPCR of rat paw AQP1 (199 bp), AQP3
(539 bp), and AQP5 (733 bp). Sequence specificity was confirmed by Southern blotting (not shown). Products were not
generated by RTPCR ...

Immunoblots prepared from rat paws were reacted with specific antibodies to AQP1–5. Membrane samples prepared from rat kidney
inner medulla and lung were positive controls. AntiAQP1 specifically reacted with 29kDa (nonglycosylated) and 35 to 40kDa
(glycosylated) forms of AQP1 in rat paws and kidney (Fig. 2A). AntiAQP3 antibodies specifically reacted with 27kDa

(nonglycosylated) and 33 to 40kDa (glycosylated) forms of AQP3 in rat skin and kidney (Fig. 2B). AntiAQP5 specifically reacted with
a 27kDa band in rat paws and lung (Fig. 2C). AntiAQP2 and antiAQP4 failed to react with samples prepared from rat paws (not
shown). Thus, the expression of AQP1, AQP3, and AQP5 were confirmed in rat paws.

Figure 2
Immunoblot analysis of rat paws, skin, kidney (inner medulla), and lung. (A) AntiAQP1 immunoblot of paw and kidney
showed 29kDa (nonglycosylated) and 35 to 40kDa glycosylated forms of AQP1. (B) AntiAQP3 immunoblot of rat
skin, kidney, and paws ...

Immunohistochemistry and Immunoelectron Microscopy. Cellular and subcellular localization of AQP1–5 were defined by immunoperoxidase
labeling of 2μm paraffin sections from rat paws (Fig. 3) and mouse paws (Fig. 4). The antiAQP1 labeling was confined to capillary
endothelial cells in rat paws (Fig. 3A), with no labeling of sweat glands or skin epithelium (Fig. 3F). As expected (26), basal levels in
skin epithelium exhibited abundant antiAQP3 labeling (Fig. 3C), but antiAQP3 labeling was not observed in sweat glands (Fig. 3H).
Moreover, antiAQP2 and antiAQP4 immunolabeling were not observed in skin (Figs. 3 B and D) or in rat sweat glands (Figs. 3 G and
I). AntiAQP5 did not label the skin epithelium (Fig. 3E). Identical antiAQP1–5 labeling patterns were observed in mouse paws (not
shown).

Figure 3
Immunoperoxidase localization of AQP1–5 in 2μm semithin paraffin sections of rat paws. (A and F) AntiAQP1 labeled
capillary structures but not epithelium (A) or sweat glands (F, *). (B and G) AntiAQP2 labeling was not observed ...

Figure 4
Immunoperoxidase localization of AQP5 in 2μm semithin paraffin sections of mouse paws and human sweat glands.
(A–D) AntiAQP5 labeling of a wildtype (+/+) mouse, revealed signal (arrows) over apical and basolateral ...

Immunohistochemical staining revealed strong antiAQP5 labeling of both apical and basolateral plasma membrane domains of the
secretory parts of mouse sweat glands (Fig. 4 A and B). The same pattern was found in rat sweat glands (not shown). The apical
membranes of proximal excretory ducts of sweat gland were also prominently labeled by antiAQP5 (Fig. 4C), whereas distal excretory
ducts were not labeled (Fig. 4D). Sections of paw from AQP5null (−/−) mice failed to react with the antiAQP5 (Fig. 4E), establishing
the specificity of the labeling pattern. Also strong antiAQP5 labeling was seen in the apical plasma membrane domains of human sweat
glands (Fig. 4F). No apparent changes occurred in the distribution or number of sweat gland profiles in the wildtype and AQP5 null
mice.
The subcellular localization of AQP5 in apical and basolateral plasma membranes of secretory cells in sweat glands was established by
immunogold electron microscopy. Abundant antiAQP5 labeling of apical plasma membranes was observed in secretory parts of mouse
sweat glands (Fig. 5 A and B). Distinct labeling was also observed in basolateral plasma membranes (Fig. 5C), consistent with the
immunohistochemical findings. Almost no intracellular labeling occurred.

Figure 5
Immunoelectron microscopy of sweat gland secretory cells in Naval Medical Research Institute mouse paw. (A and B)
AntiAQP5 labeling was observed in the apical plasma membranes (arrows); intracellular compartments were not
labeled. (C) AntiAQP5 labeling ...

Pilocarpine-Induced Sweat Response. Sections of rat and mouse paws in wildtype (+/+) and AQP5null (−/−) mice revealed no apparent
differences in the number or morphological appearance of sweat glands (Fig. 4). The ability of AQP5null (−/−) mice to secrete sweat
was evaluated by painting hindpaws with iodine and starch solution, a standard method for detecting amylase, which causes the

appearance of black spots over functional glands. Prior to pilocarpine injection (50 μg), few glands were observed (Fig. 6A), whereas
after 2 min, wildtype (+/+) mice had a higher number of visibly functional glands (arrows, Fig. 6B) than did AQP5null (−/−) mice
(arrowheads, Fig. 6D). Quantification of functional glands from six wildtype (+/+) and seven AQP5null (−/−) mice showed a
consistently lower number of active glands (23 ± 7%) in the AQP5null (−/−) mice when compared with normalized values for wild types
(100 ± 24%; Fig. 6E). Heterozygous mice (n = 3) showed a response not significantly different from wild type (data not shown).

Figure 6
Pilocarpineinduced sweat response monitored by amylase reaction with iodine/starch in mouse paw. (A) Adult AQP5
wildtype (+/+) mouse prior to (0 min) pilocarpine injection. (B) Adult AQP5 wildtype (+/+) ...

DISCUSSION
In this study, we demonstrate AQP5 expression in sweat glands by RTPCR, immunoblotting, and immunocytochemistry of rat and mouse
paws. Abundant AQP5 immunolabeling was observed in secretory cells and in the excretory duct of sweat glands. Immunoelectron
microscopy demonstrated that AQP5 labeling is predominantly associated with apical and basolateral plasma membranes of secretory
cells of mouse sweat glands with only minor labeling of intracellular structures. Pilocarpineinduced sweat responses in AQP5null (−/−)
mice were significantly reduced when compared with wildtype (+/+) and heterozygous (+/−) mice. These studies establish an essential
role for AQP5 in sweat production that may be of importance for understanding thermoregulation and the pathophysiology of hyperhidrosis
or hypohidrosis.
The localization of AQP5 in sweat glands and its possible role in sweat secretion had not previously been established. AQP1 is present in
the microvasculature (3), and fluid secretion requires substantial fluxes of water from plasma to interstitium. AQP1 has a similar
distribution in the vascular endothelial cells of rat exocrine pancreas as well as submandibular salivary glands (27) where it presumably
serves a similar function. AQP3 is present at the basal levels of skin epidermis (26). Several rat exocrine glands, including lacrimal
glands (28, 29), subepithelial glands of the upper airways (8), and submandibular and parotid salivary glands (8) contain AQP5 in the
apical membranes of acinar cells (30). In this study, we showed that AQP5 is abundant in apical membranes and is also present in
basolateral membranes of sweat glands in rat and mouse paws.
The sympathetic innervation of sweat glands elicits sweat secretion in rodents. It is not known, however, which steps are regulated by
acetylcholine or catecholamines. Postganglionic fibers in sweat glands release acetylcholine, and catecholamines have been shown to act
directly on gland cells to trigger their final differentiation for acquisition of secretory responsiveness (31). Muscarinic agonists, like
pilocarpine, mimic the ability of nerve stimulation to induce sweating (32, 33), and sweating is blocked by muscarinic antagonists (34).
Previous studies have suggested that multiple steps are involved in the coupling of muscarinic receptor stimulation to sweat secretion (32,
35). Similar to sweat glands, rat salivary glands have abundant apical AQP5 in serous gland cells where autonomic nerve systems are
innervated (8). In parotid glands, stimulation of muscarinic receptors generates inositol 1,4,5trisphosphate and diacylglycerol via
phospholipase C activation and increased phosphoinositide turnover. Generation of inositol 1,4,5trisphosphate leads to the increase in the
intracellular calcium levels (36, 37) resulting in the rapid secretion of saliva (38). This outcome may (39) possibly require translocation of
AQP5 water channel proteins to the apical plasma membrane or other forms of activation (36, 40). Consistent with this requirement,
AQP5null (−/−) mice exhibit marked reduction in pilocarpinestimulated secretion of saliva (9).
Our studies demonstrate the presence of AQP5 in sweat glands and a marked reduction in pilocarpineinduced sweat response in AQP5
deficient mice, thus raising the possibility that dysregulation of AQP5 may be important in several clinical disorders. Thus, dysregulation
of AQP5 in sweat glands may contribute to the pathogenesis of hypohidrosis observed in patients with Sjögren's syndrome in whom
markedly decreased sweating was evident in response to methacholine stimulation (14, 15). In contrast, hyperhidrosis is a chronic
idiopathic disorder of excessive sweating which may affect the palms, axillae, soles of the feet, and the face. It may be complicated by
skin maceration as well as secondary microbial infections, and all the treatment modalities are associated with several complications (41).
Our data suggest a key role of AQP5 in sweat production and raise the possibility that AQP5 inhibition may provide a new therapeutic
option for reducing excessive sweating in this clinical disorder.
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